Suppr超能文献

新型冠状病毒肺炎的新型及有争议的疗法

Novel and Controversial Therapies in COVID-19.

作者信息

Singh Romil, Shaik Likhita, Mehra Ishita, Kashyap Rahul, Surani Salim

机构信息

Department of Medicine, Metropolitan Hospital, Jaipur, Rajasthan, India.

Department of Oncology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

出版信息

Open Respir Med J. 2020 Dec 31;14:79-86. doi: 10.2174/1874306402014010079. eCollection 2020.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge of novel therapies and their publicity in recent times. Under these unprecedented circumstances, a myriad of drugs used for other diseases is being evaluated and repositioned to treat COVID-19 (example- Remdesivir, Baricitinib). While multiple trials for potential drugs and vaccines are ongoing, and there are many unproven remedies with little or no supporting evidence. Presently, discussions are revolving around the use of multivitamins (Vitamin, C, D, A), minerals (selenium, zinc), probiotics, flavonoids, polyphenols, and herbal remedies (curcumin, artemisinin, herbal drinks). Our review delves further into the details of some of these controversial therapies for COVID-19.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发了冠状病毒病(COVID-19)大流行,这促使世界各地的科学家努力寻找针对COVID-19的新型疗法。由于缺乏疫苗和特效治疗方法,近期新型疗法及其宣传激增。在这些前所未有的情况下,多种用于其他疾病的药物正在接受评估并被重新定位用于治疗COVID-19(例如瑞德西韦、巴瑞替尼)。虽然针对潜在药物和疫苗的多项试验正在进行,但也有许多未经证实的疗法,几乎没有或根本没有支持证据。目前,讨论主要围绕多种维生素(维生素C、D、A)、矿物质(硒、锌)、益生菌、类黄酮、多酚和草药疗法(姜黄素、青蒿素、草药饮品)的使用展开。我们的综述将进一步深入探讨其中一些针对COVID-19的有争议疗法的细节。

相似文献

1
Novel and Controversial Therapies in COVID-19.
Open Respir Med J. 2020 Dec 31;14:79-86. doi: 10.2174/1874306402014010079. eCollection 2020.
3
Pathogenesis-directed therapy of 2019 novel coronavirus disease.
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
4
Traditional herbs against COVID-19: back to old weapons to combat the new pandemic.
Eur J Med Res. 2022 Sep 26;27(1):186. doi: 10.1186/s40001-022-00818-5.
5
Role of Supplements in the Management of COVID-19 - A Comprehensive Review.
Infect Disord Drug Targets. 2023;23(5):e100323214544. doi: 10.2174/1871526523666230310094646.
6
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Foods. 2022 Sep 17;11(18):2884. doi: 10.3390/foods11182884.
7
Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
Viruses. 2020 Jun 30;12(7):705. doi: 10.3390/v12070705.
9
Human and novel coronavirus infections in children: a review.
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
10
Safety and Efficacy of Different Therapeutic Interventions on Prevention and Treatment of COVID-19.
J Nepal Health Res Counc. 2020 Sep 7;18(2):151-158. doi: 10.33314/jnhrc.v18i2.2806.

引用本文的文献

2
The Association of Latitude and Altitude with COVID-19 Symptoms: A VIRUS: COVID-19 Registry Analysis.
Open Respir Med J. 2022 Aug 31;16:e187430642207130. doi: 10.2174/18743064-v16-e2207130. eCollection 2022.
3
Importance of Magnesium Status in COVID-19.
Biology (Basel). 2023 May 18;12(5):735. doi: 10.3390/biology12050735.
4
COVID-19-Induced Seizures: A Meta-Analysis of Case Series and Retrospective Cohorts.
Cureus. 2022 Aug 31;14(8):e28633. doi: 10.7759/cureus.28633. eCollection 2022 Aug.
5
Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.
Front Endocrinol (Lausanne). 2022 Jun 3;13:780872. doi: 10.3389/fendo.2022.780872. eCollection 2022.
6
Association of latitude and altitude with adverse outcomes in patients with COVID-19: The VIRUS registry.
World J Crit Care Med. 2022 Mar 9;11(2):102-111. doi: 10.5492/wjccm.v11.i2.102.
8
Mortality and Severity in COVID-19 Patients on ACEIs and ARBs-A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.
Front Med (Lausanne). 2022 Jan 10;8:703661. doi: 10.3389/fmed.2021.703661. eCollection 2021.
10
Evaluation of botanicals as potential COVID-19 symptoms terminator.
World J Gastroenterol. 2021 Oct 21;27(39):6551-6571. doi: 10.3748/wjg.v27.i39.6551.

本文引用的文献

2
Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis.
Heliyon. 2021 Mar;7(3):e06515. doi: 10.1016/j.heliyon.2021.e06515. Epub 2021 Mar 14.
3
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.
Front Immunol. 2020 Jun 23;11:1512. doi: 10.3389/fimmu.2020.01512. eCollection 2020.
4
Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines.
Complement Ther Clin Pract. 2020 May;39:101174. doi: 10.1016/j.ctcp.2020.101174. Epub 2020 Apr 12.
5
Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work.
Int J Mol Sci. 2020 Apr 28;21(9):3104. doi: 10.3390/ijms21093104.
7
Enhancing immunity in viral infections, with special emphasis on COVID-19: A review.
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):367-382. doi: 10.1016/j.dsx.2020.04.015. Epub 2020 Apr 16.
8
Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?
Med Drug Discov. 2020 Mar;5:100028. doi: 10.1016/j.medidd.2020.100028. Epub 2020 Mar 26.
9
ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection.
Clin Nutr. 2020 Jun;39(6):1631-1638. doi: 10.1016/j.clnu.2020.03.022. Epub 2020 Mar 31.
10
A new clinical trial to test high-dose vitamin C in patients with COVID-19.
Crit Care. 2020 Apr 7;24(1):133. doi: 10.1186/s13054-020-02851-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验